Firm
The introduction of Canada’s patent term adjustment has left practitioners sceptical about its value, with high fees and limited eligibility meaning SMEs could lose out
With the US privacy landscape more fragmented and active than ever and federal legislation stalled, lawyers at Sheppard Mullin explain how states are taking bold steps to define their own regimes
A vote to be held in 2026 could create Hogan Lovells Cadwalader, a $3.6bn giant with 3,100 lawyers across the Americas, EMEA and Asia Pacific
Varuni Paranavitane of Finnegan and IP counsel Lisa Ribes compare and contrast two recent AI copyright decisions from Germany and the UK
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Hechanova GroupThe Intellectual Property Office of the Philippines (IPOPHL) has just issued Memorandum Circular No. 2019-024 entitled Amendments to the Rules and Regulations on Inter Partes Proceedings, which will take effect on February 15 2020. Its objective is to provide speedy, quality and effective legal remedies to resolve IP disputes. The major amendments are as follows: -
Sponsored by Hanol IP & LawRecently, the Korean Supreme Court rendered a new en banc decision finding that a final and conclusive decision granting a patent correction cannot constitute a ground for retrial.
-
Sponsored by Tilleke & GibbinsThe concept of corporate criminal liability was introduced into Vietnamese law under the Penal Code of 2015, which took effect in 2018. Under the 2015 Penal Code, for the first time, corporate entities (companies) could be held criminally liable for a variety of offences, including certain intellectual property crimes under Articles 225 and 226.
-
Sponsored by Basham Ringe y CorreaEduardo Kleinberg and Santiago Zubikarai of Basham evaluate the new industrial property legislation under consideration in Mexico, assessing changes to the law on damages, fines, the registration of trademarks and patents
-
Sponsored by Hechanova GroupThe TRIPS Agreement, to which the Philippines is a signatory, enables governments of member countries with no capacity to manufacture medicines to import/export cheaper pharmaceutical products via a compulsory licence. These are medicines for which they would otherwise have paid a higher price because of existing patents.
-
Sponsored by AnJie Law FirmOn December 25 2019, the Supreme Court promulgated amendments of Several Provisions on Civil Evidence Rules (amendments). The amendments, which will come into effect on May 1 2020, have attracted lots of attention from IP practitioners. The rules are expected to improve the accuracy and standardisation of evidence production procedures and balance the burden of proof between litigants. Below are some highlights of the amendments.
